FlowCell distributes and develops microfluidic tools for drug discovery. The preclinical tools help to increase physiological value of biological models using 3D / organoid cultures with perfusion of media. FlowCell is developing tools for measurement for biomarkers in clinical trial setting to improve drug development by providing tools for companion diagnostics that also enable personalized medicine during treatment. Pre-clinical tools are of interest for fundamental research, early drug development, including toxicololgy, dosing / ADME / PKPD. Clinical tools are of interest to pharma, and hospitals which run majority of clinical trials and also provide care to patients after drug approval. FlowCell tools will enable personalized medicine resulting in improved outcomes for patients. This translates into faster regulatory approval, and builds brands for drugs with biomarkers that allow precision medicine.
